Advertisement
Review Article| Volume 43, ISSUE 4, P743-755, December 2022

Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Andersen D.H.
        Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study.
        Am J Dis Child. 1938; 56: 344-399
      1. Moshiree B., Freeman A.J., Vu P., et al., Multicenter prospective study of gastrointestinal symptom prevalence and severity in CF: GALASY results, Pediatr Pulmonol, 55 (S2), 2020, 127 (Abstract 227).

        • Revicki D.A.
        • Rentz A.M.
        • Tack J.
        • et al.
        Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders.
        Clin Gastroenterol Hepatol. 2004; 2: 769-777
        • Slappendel R.
        • Simpson K.
        • Dubois D.
        • et al.
        Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain.
        Eur J Pain. 2006; 10: 209-217
        • Marquis P.
        • De La Loge C.
        • Dubois D.
        • et al.
        Development and validation of the patient Assessment of constipation quality of life questionnaire.
        Scand J Gastroenterol. 2005; 40: 540-551
        • Maqbool A.
        • Pauwels A.
        Cystic Fibrosis and gastroesophageal reflux disease.
        J Cyst Fibros. 2017; 16: S2-S13
        • Lightdale J.R.
        • Gremse D.A.
        • Section on Gastroenterology, Hepatology, and Nutrition
        Gastroesophageal reflux: management guidance for the pediatrician.
        Pediatrics. 2013; 131: e1684-e1695
        • Robinson N.B.
        • DiMango E.
        Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease.
        Ann Am Thorac Soc. 2014; 11: 964-968
        • Pauwels A.
        • Blondeau K.
        • Dupont L.J.
        • et al.
        Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis.
        Am J Gastroenterol. 2012; 107: 1346-1353
        • Omari T.
        Gastro-oesophagel reflux disease and children: new insights, developments and old chestnuts.
        J Pediatr Gastroenterol Nutr. 2005; 41: S21-S23
        • Button B.M.
        • Roberts S.
        • Kotsimbos T.C.
        • et al.
        Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation.
        J Heart Lung Transpl. 2005; 24: 1522-1529
        • Ledson M.J.
        • Tran J.
        • Walshaw M.J.
        Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients.
        J R Soc Med. 1998; 91: 7-9
        • Katz P.O.
        • Dunbar K.B.
        • Schnoll-Sussman F.H.
        • et al.
        ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease.
        Am J Gastroenterol. 2022; 117: 27-56
        • Gyawali C.P.
        • Carlson D.A.
        • Chen J.W.
        • et al.
        ACG clinical guidelines: clinical use of esophageal physiologic testing.
        Am J Gastroenterol. 2020; 115: 1412-1428
        • Freedberg D.E.
        • Kim L.S.
        • Yang Y.X.
        The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association.
        Gastroenterology. 2017; 152: 706-715
        • Lindkvist B.
        Diagnosis and treatment of pancreatic exocrine insufficiency.
        World J Gastroenterol. 2013; 19: 7258-7266
        • Ayoub F.
        • Lascano J.
        • Morelli G.
        Proton pump inhibitor use is associated with an increased frequency of hospitalization in patients with cystic fibrosis.
        Gastroenterol Res. 2017; 10: 288-293
        • Ng J.
        • Friedmacher F.
        • Pao C.
        • et al.
        Gastroesophageal reflux disease and need for antireflux surgery in children with cystic fibrosis: a systematic review on incidence, surgical complications, and postoperative outcomes.
        Eur J Pediatr Surg. 2021; 31: 106-114
        • Richter J.E.
        • Kumar A.
        • Lipka S.
        • et al.
        Efficacy of laparoscopic nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis.
        Gastroenterology. 2018; 154: 1298-1308 e7
        • Dorsey J.
        • Gonska T.
        Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine.
        J Cyst Fibros. 2017; 16: S14-S23
        • Saltzman M.B.
        • McCallum R.W.
        Diabetes and the stomach.
        Yale J Biol Med. 1983; 56: 179-187
        • Navas C.M.
        • Patel N.K.
        • Lacy B.E.
        Gastroparesis: medical and therapeutic advances.
        Dig Dis Sci. 2017; 62: 2231-2240
        • Sullivan A.
        • Temperley L.
        • Ruban A.
        Pathophysiology, aetiology and treatment of gastroparesis.
        Dig Dis Sci. 2020; 65: 1615-1631
        • Pasricha P.J.
        • Grover M.
        • Yates K.P.
        • et al.
        Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features.
        Gastroenterology. 2021; 160: 2006-2017
        • Corral J.E.
        • Dye C.W.
        • Mascarenhas M.R.
        • et al.
        Is Gastroparesis found more frequently in patients with cystic fibrosis? a systematic review.
        Scientifica (Cairo). 2016; 2016: 2918139
        • Du Y.T.
        • Rayner C.K.
        • Jones K.L.
        • et al.
        Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management.
        Diabetes Care. 2018; 41: 627-637
        • Bharucha A.E.
        • Kudva Y.C.
        • Prichard D.O.
        Diabetic gastroparesis.
        Endocr Rev. 2019; 40: 1318-1352
        • de Boer S.Y.
        • Masclee A.A.
        • Lamers C.B.
        Effect of hyperglycemia on gastrointestinal and gallbladder motility.
        Scand J Gastroenterol Suppl. 1992; 194: 13-18
        • Keshavarzian A.
        • Iber F.L.
        Gastrointestinal involvement in insulin-requiring diabetes mellitus.
        J Clin Gastroenterol. 1987; 9: 685-692
        • Rayner C.K.
        • Samsom M.
        • Jones K.L.
        • et al.
        Relationships of upper gastrointestinal motor and sensory function with glycemic control.
        Diabetes Care. 2001; 24: 371-381
        • Szarka L.A.
        • Camilleri M.
        Methods for the assessment of small-bowel and colonic transit.
        Semin Nucl Med. 2012; 42: 113-123
        • Saad R.J.
        • Hasler W.L.
        A technical review and clinical assessment of the wireless motility capsule.
        Gastroenterol Hepatol (N Y). 2011; 7: 795-804
        • Camilleri M.
        • Parkman H.P.
        • Shafi M.A.
        • et al.
        Clinical guideline: management of gastroparesis.
        Am J Gastroenterol. 2013; 108 ([quiz: 38]): 18-37
        • Lebares C.
        • Swanstrom L.L.
        Per-oral pyloromyotomy (POP): an emerging application of submucosal tunneling for the treatment of refractory gastroparesis.
        Gastrointest Endosc Clin N Am. 2016; 26: 257-270
        • Lewindon P.J.
        • Robb T.A.
        • Moore D.J.
        • et al.
        Bowel dysfunction in cystic fibrsis: importance of breath testing.
        J Paediatr Child Health. 1998; 34: 79-82
        • Furnari M.
        • De Alessandri A.
        • Cresta F.
        • et al.
        The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
        J Gastroenterol. 2019; 54: 261-270
        • Shah S.C.
        • Day L.W.
        • Somsouk M.
        • et al.
        Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.
        Aliment Pharmacol Ther. 2013; 38: 925-934
        • Ahmed N.
        • Corey M.
        • Forstner G.
        • et al.
        Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.
        Gut. 2003; 52: 1159-1164
        • Assis D.N.
        • Freedman S.D.
        Gastrointestinal disorders in cystic fibrosis.
        Clin Chest Med. 2016; 37: 109-118
        • Gonzalez-Sanchez V.
        • Amrani R.
        • Gonzalez V.
        • et al.
        Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-mixed triglyceride breath test versus fecal elastase.
        Pancreatology. 2017; 17: 580-585
        • Beharry S.
        • Ellis L.
        • Corey M.
        • et al.
        How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?.
        J Pediatr. 2002; 141: 84-90
        • Walkowiak J.
        • Nousia-Arvanitakis S.
        • Agguridaki C.
        • et al.
        Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patgients using the fecal elastase-1 test.
        J Pediatr Gastroenterol Nutr. 2003; 36: 474-478
        • Somaraju U.R.R.
        • Solis-Moya A.
        Pancreatic enzyme replacement therapy for people with cystic fibrosis.
        Cochrane Database Syst Rev. 2020; 5: CD008227
        • Stevens J.
        • Wyatt C.
        • Brown P.
        • et al.
        Absorption and safety with sustained use of RELiZORB Evaluation (ASSURE) study in patients with cystic fibrosis receiving enteral feeding.
        J Pediatr Gastroenterol Nutr. 2018; 67: 527-532
        • Durno C.
        • Corey M.
        • Zielinski J.
        • et al.
        Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis.
        Gastroenterology. 2002; 123: 1857-1864
        • Leung D.H.
        • Narkewicz M.R.
        Cystic fibrosis-related cirrhosis.
        J Cyst Fibros. 2017; : S50-S61
        • Assis D.N.
        • Debray D.
        Gallbladder and bile duct disease in Cystic Fibrosis.
        J Cyst Fibros. 2017; : S62-S69
        • Cohn J.A.
        • Strong T.V.
        • Picciotto M.R.
        • et al.
        Locatlization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.
        Gastroenterology. 1993; 106: 1857-1864
        • Colombo C.
        • Battezzati P.M.
        • Crosignani A.
        • et al.
        Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome.
        Hepatology. 2002; 36: 1374-1382
        • Debray D.
        Cystic fibrosis associated with liver disease.
        Arch Pediatr. 2012; : S23-S26
        • Flass T.
        • Narkewicz M.R.
        Cirrhosis and other liver disease in cystic fibrosis.
        J Cyst Fibros. 2013; 12: 116-124
        • Koh C.
        • Sakiani S.
        • Surana P.
        • et al.
        Adult-onset cystic fibrosis liver disease: diagnosis and characterization of an underappreciated entity.
        Hepatology. 2017; 66: 591-601
        • Siegel M.J.
        • Freeman A.J.
        • Ye W.
        • et al.
        Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease: interim results of a prospective observational case-controlled study.
        J Pediatr. 2020; 219: 62-69
        • Klotter V.
        • Gunchick C.
        • Siemers E.
        • et al.
        Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study.
        PLoS One. 2017; 12: e0178784
        • Lewindon P.J.
        • Puertolas-Lopez M.V.
        • Ramm L.E.
        • et al.
        Accuracy of transient elastography data combined with APRI in detection and staging of liver disease in pediatric patients with cystic fibrosis.
        Clin Gastroenterol Hepatol. 2019; 17: 2561-2569
        • Wu H.
        • Vu M.
        • Dhingra S.
        • et al.
        Obliterative portal venopahty without cirrhosis is prevalent in pediatric cystic fibrosis liver disease with portal hypertension.
        Clin Gastroenterol Hepatol. 2019; 17: 2134-2136
        • Witters P.
        • Libbrecht L.
        • Roskams T.
        • et al.
        Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension.
        J Cyst Fibros. 2017; 16: e11-e13
        • Hillaire S.
        • Cazals-Hatem D.
        • Bruno O.
        • et al.
        Liver transplantation in adult cystic fibrosis: clinical, imaging, and pathological evidence of obliterative portal venopathy.
        Liver Transpl. 2017; 23: 1342-1347
        • Durieu I.
        • Pellet O.
        • Simonot L.
        • et al.
        Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study.
        J Hepatol. 1999; 30: 1052-1056
        • Sathe M.
        • Houwen R.
        Meconium ileus in cystic fibrosis.
        J Cyst Fibros. 2017; 16: S32-S39
        • Abraham J.
        • Taylor C.
        Cystic Fibrosis & disorders of the large intestine: DIOS, constipation, and colorectal cancer.
        J cystic fibrosis. 2017; 16
        • Hadjiliadis D.
        • Khoruts A.
        • Zauber A.G.
        • et al.
        Cystic Fibrosis colorectal cancer screening consensus recommendations.
        Gastroenterology. 2018; 154: 736-745